Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00478764 · ClinicalTrials.gov registry record · NA
Intraocular Steroid After Cataract Surgery Study
A NA study of Cataract, sponsored by Dean Health System.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT00478764: Completed NA study of Cataract, sponsored by Dean Health System.
NCT00478764 is a NA study of Cataract that has completed, run by Dean Health System. The registered enrollment target is 41 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00478764, a NA study of Cataract, has completed, sponsored by Dean Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The use of one dose of an antibiotic and steroid injected into the eye at the end of cataract surgery is as safe and effective as the post operative use of eyedrops after cataract surgery.
Conditions Studied
Interventions
- DRUG intraocular triamcinolone and gatifloxicin
Study Locations (1)
Wisconsin
- Davis Duehr Dean Baraboo - Baraboo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-04 |
| Phase | NA |
What the finished NCT00478764 record still lists
NCT00478764 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which intraocular triamcinolone and gatifloxicin is the first listed.
NCT00478764 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00478764 about?
NCT00478764 is a clinical study titled "Intraocular Steroid After Cataract Surgery Study". The use of one dose of an antibiotic and steroid injected into the eye at the end of cataract surgery is as safe and effective as the post operative use of eyedrops after cataract surgery.
What is the current status of trial NCT00478764?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2006-03. Estimated completion is 2007-04.
What conditions does trial NCT00478764 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT00478764?
The interventions under investigation include: intraocular triamcinolone and gatifloxicin (DRUG).
Who is sponsoring clinical trial NCT00478764?
This trial is sponsored by Dean Health System, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00478764 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00478764's enrollment target sits among peer trials
41 64th of 83 higher than 20 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
Quatera 700 vs. Centurion
ACTIVE NOT RECRUITING · NA
-
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
ACTIVE NOT RECRUITING · NA
-
Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia